SUMMIT Study Shows Off Power Of Mass Cancer Screening
SUMMIT, the landmark study conducted within the UK focused on diagnosing lung cancer before it becomes untreatable, has demonstrated the practicality and cost effectiveness of mass CT screening.
You may also be interested in...
Allelica, a company specializing in diagnostics "software as a service," has obtained $1.75m in seed funding to bring genomic risk prediction to the forefront of patient care.
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
David Caumartin is well versed in the both the benefits and drawbacks of being a France-based medtech innovator, having spent almost three decades in the local industry. The VP of France Biotech spoke to Medtech Insight about the new opportunities there to be seized, and the pitfalls to avoid.